Differential CD4(+) versus CD8(+) T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates

Ítems similars

• Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens
  per: Mooij, Petra, et al.
  Publicat: (2009)
• Long-Lived Poxvirus Immunity, Robust CD4 Help, and Better Persistence of CD4 than CD8 T Cells
  per: Amara, Rama Rao, et al.
  Publicat: (2004)
• Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site
  per: Bogers, Willy M. J. M., et al.
  Publicat: (2017)
• Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic
  per: Corbett, Max, et al.
  Publicat: (2008)
• Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds
  per: Madani, Navid, et al.
  Publicat: (2016)